- Home
- NMTC vs COEP Comparison
NMTC vs COEP Comparison
Compare NMTC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- COEP
- Stock Information
- Founded
- NMTC 2009
- COEP 2017
- Country
- NMTC United States
- COEP United States
- Employees
- NMTC N/A
- COEP N/A
- Industry
- NMTC Medical/Dental Instruments
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NMTC Health Care
- COEP Health Care
- Exchange
- NMTC Nasdaq
- COEP Nasdaq
- Market Cap
- NMTC 30.9M
- COEP 32.0M
- IPO Year
- NMTC N/A
- COEP N/A
- Fundamental
- Price
- NMTC $0.73
- COEP $8.03
- Analyst Decision
- NMTC Strong Buy
- COEP
- Analyst Count
- NMTC 1
- COEP 0
- Target Price
- NMTC $1.45
- COEP N/A
- AVG Volume (30 Days)
- NMTC 202.7K
- COEP 25.9K
- Earning Date
- NMTC 08-13-2025
- COEP 08-15-2025
- Dividend Yield
- NMTC N/A
- COEP N/A
- EPS Growth
- NMTC N/A
- COEP N/A
- EPS
- NMTC N/A
- COEP N/A
- Revenue
- NMTC $5,758,777.00
- COEP $62,874.00
- Revenue This Year
- NMTC $141.04
- COEP N/A
- Revenue Next Year
- NMTC $38.86
- COEP N/A
- P/E Ratio
- NMTC N/A
- COEP N/A
- Revenue Growth
- NMTC 54.53
- COEP N/A
- 52 Week Low
- NMTC $0.40
- COEP $2.31
- 52 Week High
- NMTC $1.39
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- NMTC 66.15
- COEP 43.91
- Support Level
- NMTC $0.66
- COEP $6.80
- Resistance Level
- NMTC $0.77
- COEP $8.86
- Average True Range (ATR)
- NMTC 0.05
- COEP 0.62
- MACD
- NMTC 0.02
- COEP -0.05
- Stochastic Oscillator
- NMTC 81.31
- COEP 45.88
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.